International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Authors: Wise Sarah K. , Damask Cecelia , Roland Lauren T. , Ebert Charles , Levy Joshua M. , Lin Sandra , Luong Amber , Rodriguez Kenneth , Sedaghat Ahmad R. , Toskala Elina , Villwock Jennifer , Abdullah Baharudin , Akdis Cezmi , Alt Jeremiah A. , Ansotegui Ignacio J. , Azar Antoine , Baroody Fuad , Benninger Michael S. , Bernstein Jonathan , Brook Christopher , Campbell Raewyn , Casale Thomas , Chaaban Mohamad R. , Chew Fook Tim , Chambliss Jeffrey , Cianferoni Antonella , Custovic Adnan , Davis Elizabeth Mahoney , DelGaudio John M. , Ellis Anne K. , Flanagan Carrie , Fokkens Wytske J. , Franzese Christine , Greenhawt Matthew , Gill Amarbir , Halderman Ashleigh , Hohlfeld Jens M. , Incorvaia Cristoforo , Joe Stephanie A. , Joshi Shyam , Kuruvilla Merin Elizabeth , Kim Jean , Klein Adam M. , Krouse Helene J. , Kuan Edward C. , Lang David , Larenas‐Linnemann Desiree , Laury Adrienne M. , Lechner Matt , Lee Stella E. , Lee Victoria S. , Loftus Patricia , Marcus Sonya , Marzouk Haidy , Mattos Jose , McCoul Edward , Melen Erik , Mims James W. , Mullol Joaquim , Nayak Jayakar V. , Oppenheimer John , Orlandi Richard R. , Phillips Katie , Platt Michael , Ramanathan Murugappan , Raymond Mallory , Rhee Chae‐Seo , Reitsma Sietze , Ryan Matthew , Sastre Joaquin , Schlosser Rodney J. , Schuman Theodore A. , Shaker Marcus S. , Sheikh Aziz , Smith Kristine A. , Soyka Michael B. , Takashima Masayoshi , Tang Monica , Tantilipikorn Pongsakorn , Taw Malcolm B. , Tversky Jody , Tyler Matthew A. , Veling Maria C. , Wallace Dana , Wang De Yun , White Andrew , Zhang Luo 
Published: March 2023

AbstractBackgroundIn the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document.MethodsICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work.ResultsICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost.ConclusionThe ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.